20
Anjan Drug Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GABAPENTIN USP, with a corresponding US DMF Number 22765.
Remarkably, this DMF maintains an Active status since its submission on May 08, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 29, 2014, and payment made on November 21, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II